Max Robotics — Global Service Robot Directory + US Certification

About

Katherine Pulman is a leading gynecologic oncologist whose research has fundamentally reshaped surgical staging for high-risk endometrial cancer. Her landmark 2020 study, cited over 220 times, provided critical evidence that sentinel lymph node biopsy (SLNB) can safely replace full lymphadenectomy in intermediate- and high-grade endometrial cancer, reducing surgical morbidity without compromising diagnostic accuracy. This work has directly influenced international clinical guidelines, sparing countless patients the complications of extensive lymph node dissection. Dr. Pulman has also advanced minimally invasive surgical techniques, demonstrating the feasibility and safety of laparoscopy and robotic surgery for obese and morbidly obese patients—a population historically at higher surgical risk. Her comparative analysis of laparotomy, laparoscopy, and robotic approaches for staging lymphadenectomy in high-risk endometrial cancer further clarified the benefits of minimally invasive methods. Through these contributions, Dr. Pulman has improved both oncologic outcomes and quality of life for women with gynecologic cancers, establishing herself as a pivotal figure in the evolution of precision surgical staging.